amlodipine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Amlodipine is a long-acting dihydropyridine and inappropriate dosage poses a great threat for profound vasodilation, hypotension, and refractory vasopressor-resistant shock." | 8.12 | Refractory Shock from Amlodipine Overdose Overcomed with Hyperinsulinemia. ( Kakava, K; Koliastasis, L; Lampadakis, I; Milkas, A; Papaioannou, S; Sourides, V; Strempelas, P; Tsioufis, P, 2022) |
| " Amlodipine is a long-acting dihydropyridine and inappropriate dosage poses a great threat for profound vasodilation, hypotension, and refractory vasopressor-resistant shock." | 4.12 | Refractory Shock from Amlodipine Overdose Overcomed with Hyperinsulinemia. ( Kakava, K; Koliastasis, L; Lampadakis, I; Milkas, A; Papaioannou, S; Sourides, V; Strempelas, P; Tsioufis, P, 2022) |
| " The former dosage of ACEis/ARBs was continued in one group while in another group, the ACEis/ARBs were replaced by amlodipine ± carvedilol according to the dose equivalents." | 3.01 | Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial. ( Ashraf, H; Bahreini, M; Ghoghaei, M; Najmeddin, F; Rasooli, F; Salehi, M; Soleimani, A; Solhjoo, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koliastasis, L | 1 |
| Lampadakis, I | 1 |
| Milkas, A | 1 |
| Strempelas, P | 1 |
| Sourides, V | 1 |
| Kakava, K | 1 |
| Tsioufis, P | 1 |
| Papaioannou, S | 1 |
| Loas, G | 1 |
| Le Corre, P | 1 |
| Nouri-Vaskeh, M | 1 |
| Kalami, N | 1 |
| Zand, R | 1 |
| Soroureddin, Z | 1 |
| Varshochi, M | 1 |
| Ansarin, K | 1 |
| Rezaee, H | 1 |
| Taghizadieh, A | 1 |
| Sadeghi, A | 1 |
| Ahangari Maleki, M | 1 |
| Esmailnajad, A | 1 |
| Saleh, P | 1 |
| Haghdoost, M | 1 |
| Maleki, M | 1 |
| Sharifi, A | 1 |
| Najmeddin, F | 1 |
| Solhjoo, M | 1 |
| Ashraf, H | 1 |
| Salehi, M | 1 |
| Rasooli, F | 1 |
| Ghoghaei, M | 1 |
| Soleimani, A | 1 |
| Bahreini, M | 1 |
2 trials available for amlodipine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; COVID-19; Double-Blind | 2021 |
Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.
Topics: Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2021 |
2 other studies available for amlodipine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Refractory Shock from Amlodipine Overdose Overcomed with Hyperinsulinemia.
Topics: Aged; Amlodipine; Calcium Channel Blockers; COVID-19; Drug Overdose; Female; Humans; Hyperinsulinism | 2022 |
Comment on 'Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial'.
Topics: Amlodipine; Antihypertensive Agents; COVID-19; Humans; Hypertension; Losartan; SARS-CoV-2 | 2021 |